COMPLIANCE INFO - Laserfiche WebLink

Home Browse Search

� e Information on the Hepatitis B Vaccine [Recombinant] Hepatitis Hepatitis is a serious viral infection of the liver. The most severe form of Hepatitis is caused by a virus known as Hepatitis B. Every year 18,000 health care workers in America contract Hepatitis B. Most patients infected with Hepatitis B have no symptoms but 25%will develop a prolonged illness and some may die from the illness. Hepatitis b can be spread to health care workers by accidental needle stick or other exposes to blood or body fluids of Hepatitis b infected patients. Your risk of contracting Hepatitis B from a needle stick with a Hepatitis B contaminated needle is 35- 40%. The risk from a splash to your eyes,mouth,or skin with Hepatitis infected blood or body fluid is much less. There is no known cure once a patient is infected,but a vaccine is available which can effectively prevent Hepatitis B infection even if you are accidently exposed to Hepatitis B infected blood or body fluids. Health care workers are at a high risk of acquiring Hepatitis B because of their frequent contact with blood and/or other infectious materials. Vanderbilt wants to protect you from this illness and strongly recommends that you become vaccinated with Hepatitis B vaccine if you could reasonably anticipate any occupational exposure to blood and/or other infections materials in accordance with the recommendations by the CDC(Center for Disease Control)and in compliance with the OSHA Bloodborne Pathogen Standard issued 12-2-91,governing exposure to bloodborne pathogens. Hepatitis B Vaccine Hepatitis B Vaccine [Recombinant] is a non-infectious Recombinant DNA Hepatitis B Vaccine. It is approved by the FDA to be given 3 intramuscular doses of 1 cc at time), 1 month and 6 months. Approximately 9011/c of persons vaccinated by this route will develop antibodies to Hepatitis B and will be protected. Adverse Reactions to Hepatitis B Vaccine Hepatitis B Vaccine[Recombinant] is generally well tolerated. During clinical studies involving over 10,000 individuals distributed over all age groups,no serious adverse reactions attributable to vaccine administration were reported. As with any vaccine, however,is possible that expanded commercial use of the vaccine could reveal rare adverse reactions not observed in clinical studies. The most frequently reported adverse reactions were IM injection-site soreness,fatigue,induration,erythema,swelling,fever, headache,and dizziness. Other more serious adverse reactions have occurred infrequently. If you have any questions about Hepatitis B Vaccine [Recombinant]please ask an Employee Health Service health care provider prior to deciding whether to accept the vaccine. Contraindications Hypersensitivity to yeast or any other component(e.g.thimerosal)of the vaccine is a contraindication for use of the vaccine. Warnings Patients experiencing hypersensitivity after a Hepatitis B Vaccine[Recombinant]injection IM should not receive further injections of Hepatitis B Vaccine[Recombinant] (see Contraindications). Hepatitis B has a long incubation period. Hepatitis B vaccination may not prevent Hepatitis B infection in individuals who have an unrecognized Hepatitis B infection at the time of vaccine and do not develop immunity to the Hepatitis B Virus. Pre2nancy Animal reproduction studies have not been conducted with Hepatitis B Vaccine[Recombinant]. It is also not known whether Hepatitis B Vaccine[Recombinant]can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Hepatitis B Vaccine[Recombinant] should be given to a pregnant woman only if clearly needed. Nursing Mothers It is known whether Hepatitis B Vaccine[Recombinant] is excreted in human milk. Because many drugs are excreted in human milk,caution should be exercised when Hepatitis Vaccine[Recombinant] is administered to a nursing woman.